Cargando…

Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate

BACKGROUND: Droplets and aerosols produced during dental procedures are a risk factor for microbial and viral transmission. Unlike sodium hypochlorite, hypochlorous acid (HOCl) is nontoxic to tissues but still exhibits broad microbicidal effect. HOCl solution may be applicable as a supplement to wat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tazawa, Kento, Jadhav, Rutuja, Azuma, Mariane Maffei, Fenno, J. Christopher, McDonald, Neville J., Sasaki, Hajime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938691/
https://www.ncbi.nlm.nih.gov/pubmed/36803460
http://dx.doi.org/10.1186/s12903-023-02820-7
_version_ 1784890686933303296
author Tazawa, Kento
Jadhav, Rutuja
Azuma, Mariane Maffei
Fenno, J. Christopher
McDonald, Neville J.
Sasaki, Hajime
author_facet Tazawa, Kento
Jadhav, Rutuja
Azuma, Mariane Maffei
Fenno, J. Christopher
McDonald, Neville J.
Sasaki, Hajime
author_sort Tazawa, Kento
collection PubMed
description BACKGROUND: Droplets and aerosols produced during dental procedures are a risk factor for microbial and viral transmission. Unlike sodium hypochlorite, hypochlorous acid (HOCl) is nontoxic to tissues but still exhibits broad microbicidal effect. HOCl solution may be applicable as a supplement to water and/or mouthwash. This study aims to evaluate the effectiveness of HOCl solution on common human oral pathogens and a SARS-CoV-2 surrogate MHV A59 virus, considering the dental practice environment. METHODS: HOCl was generated by electrolysis of 3% hydrochloric acid. The effect of HOCl on human oral pathogens, Fusobacterium nucleatum, Prevotella intermedia, Streptococcus intermedius, Parvimonas micra, and MHV A59 virus was studied from four perspectives: concentration; volume; presence of saliva; and storage. HOCl solution in different conditions was utilized in bactericidal and virucidal assays, and the minimum inhibitory volume ratio that is required to completely inhibit the pathogens was determined. RESULTS: In the absence of saliva, the minimum inhibitory volume ratio of freshly prepared HOCl solution (45–60 ppm) was 4:1 for bacterial suspensions and 6:1 for viral suspensions. The presence of saliva increased the minimum inhibitory volume ratio to 8:1 and 7:1 for bacteria and viruses, respectively. Applying a higher concentration of HOCl solution (220 or 330 ppm) did not lead to a significant decrease in the minimum inhibitory volume ratio against S. intermedius and P. micra. The minimum inhibitory volume ratio increases in applications of HOCl solution via the dental unit water line. One week of storage of HOCl solution degraded HOCl and increased the minimum growth inhibition volume ratio. CONCLUSIONS: HOCl solution (45–60 ppm) is still effective against oral pathogens and SAR-CoV-2 surrogate viruses even in the presence of saliva and after passing through the dental unit water line. This study indicates that the HOCl solution can be used as therapeutic water or mouthwash and may ultimately reduce the risk of airborne infection in dental practice.
format Online
Article
Text
id pubmed-9938691
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99386912023-02-20 Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate Tazawa, Kento Jadhav, Rutuja Azuma, Mariane Maffei Fenno, J. Christopher McDonald, Neville J. Sasaki, Hajime BMC Oral Health Research BACKGROUND: Droplets and aerosols produced during dental procedures are a risk factor for microbial and viral transmission. Unlike sodium hypochlorite, hypochlorous acid (HOCl) is nontoxic to tissues but still exhibits broad microbicidal effect. HOCl solution may be applicable as a supplement to water and/or mouthwash. This study aims to evaluate the effectiveness of HOCl solution on common human oral pathogens and a SARS-CoV-2 surrogate MHV A59 virus, considering the dental practice environment. METHODS: HOCl was generated by electrolysis of 3% hydrochloric acid. The effect of HOCl on human oral pathogens, Fusobacterium nucleatum, Prevotella intermedia, Streptococcus intermedius, Parvimonas micra, and MHV A59 virus was studied from four perspectives: concentration; volume; presence of saliva; and storage. HOCl solution in different conditions was utilized in bactericidal and virucidal assays, and the minimum inhibitory volume ratio that is required to completely inhibit the pathogens was determined. RESULTS: In the absence of saliva, the minimum inhibitory volume ratio of freshly prepared HOCl solution (45–60 ppm) was 4:1 for bacterial suspensions and 6:1 for viral suspensions. The presence of saliva increased the minimum inhibitory volume ratio to 8:1 and 7:1 for bacteria and viruses, respectively. Applying a higher concentration of HOCl solution (220 or 330 ppm) did not lead to a significant decrease in the minimum inhibitory volume ratio against S. intermedius and P. micra. The minimum inhibitory volume ratio increases in applications of HOCl solution via the dental unit water line. One week of storage of HOCl solution degraded HOCl and increased the minimum growth inhibition volume ratio. CONCLUSIONS: HOCl solution (45–60 ppm) is still effective against oral pathogens and SAR-CoV-2 surrogate viruses even in the presence of saliva and after passing through the dental unit water line. This study indicates that the HOCl solution can be used as therapeutic water or mouthwash and may ultimately reduce the risk of airborne infection in dental practice. BioMed Central 2023-02-18 /pmc/articles/PMC9938691/ /pubmed/36803460 http://dx.doi.org/10.1186/s12903-023-02820-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tazawa, Kento
Jadhav, Rutuja
Azuma, Mariane Maffei
Fenno, J. Christopher
McDonald, Neville J.
Sasaki, Hajime
Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate
title Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate
title_full Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate
title_fullStr Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate
title_full_unstemmed Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate
title_short Hypochlorous acid inactivates oral pathogens and a SARS-CoV-2-surrogate
title_sort hypochlorous acid inactivates oral pathogens and a sars-cov-2-surrogate
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938691/
https://www.ncbi.nlm.nih.gov/pubmed/36803460
http://dx.doi.org/10.1186/s12903-023-02820-7
work_keys_str_mv AT tazawakento hypochlorousacidinactivatesoralpathogensandasarscov2surrogate
AT jadhavrutuja hypochlorousacidinactivatesoralpathogensandasarscov2surrogate
AT azumamarianemaffei hypochlorousacidinactivatesoralpathogensandasarscov2surrogate
AT fennojchristopher hypochlorousacidinactivatesoralpathogensandasarscov2surrogate
AT mcdonaldnevillej hypochlorousacidinactivatesoralpathogensandasarscov2surrogate
AT sasakihajime hypochlorousacidinactivatesoralpathogensandasarscov2surrogate